BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 18663124)

  • 1. EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2.
    Lünemann JD; Jelcić I; Roberts S; Lutterotti A; Tackenberg B; Martin R; Münz C
    J Exp Med; 2008 Aug; 205(8):1763-73. PubMed ID: 18663124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.
    Lünemann JD; Edwards N; Muraro PA; Hayashi S; Cohen JI; Münz C; Martin R
    Brain; 2006 Jun; 129(Pt 6):1493-506. PubMed ID: 16569670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heightened Epstein-Barr virus immunity and potential cross-reactivities in multiple sclerosis.
    Thomas OG; Haigh TA; Croom-Carter D; Leese A; Van Wijck Y; Douglas MR; Rickinson A; Brooks JM; Taylor GS
    PLoS Pathog; 2024 Jun; 20(6):e1012177. PubMed ID: 38843296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term carriers generate Epstein-Barr virus (EBV)-specific CD4(+) and CD8(+) polyfunctional T-cell responses which show immunodominance hierarchies of EBV proteins.
    Ning RJ; Xu XQ; Chan KH; Chiang AK
    Immunology; 2011 Oct; 134(2):161-71. PubMed ID: 21896011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.
    Jilek S; Schluep M; Meylan P; Vingerhoets F; Guignard L; Monney A; Kleeberg J; Le Goff G; Pantaleo G; Du Pasquier RA
    Brain; 2008 Jul; 131(Pt 7):1712-21. PubMed ID: 18550621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct memory CD4+ T-cell subsets mediate immune recognition of Epstein Barr virus nuclear antigen 1 in healthy virus carriers.
    Heller KN; Upshaw J; Seyoum B; Zebroski H; Münz C
    Blood; 2007 Feb; 109(3):1138-46. PubMed ID: 16985171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis.
    Pender MP; Csurhes PA; Lenarczyk A; Pfluger CM; Burrows SR
    J Neurol Neurosurg Psychiatry; 2009 May; 80(5):498-505. PubMed ID: 19015225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function.
    Bickham K; Münz C; Tsang ML; Larsson M; Fonteneau JF; Bhardwaj N; Steinman R
    J Clin Invest; 2001 Jan; 107(1):121-30. PubMed ID: 11134187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine model.
    Jog NR; McClain MT; Heinlen LD; Gross T; Towner R; Guthridge JM; Axtell RC; Pardo G; Harley JB; James JA
    J Autoimmun; 2020 Jan; 106():102332. PubMed ID: 31515129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1.
    Münz C; Bickham KL; Subklewe M; Tsang ML; Chahroudi A; Kurilla MG; Zhang D; O'Donnell M; Steinman RM
    J Exp Med; 2000 May; 191(10):1649-60. PubMed ID: 10811859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease-Modifying Treatments for Multiple Sclerosis Affect Measures of Cellular Immune Responses to EBNA-1 Peptides.
    Dungan L; Dunne J; Savio M; Kalaszi M; McElheron M; Lynagh Y; O'Driscoll K; Roche C; Qureshi A; Crowley B; Conlon N; Kearney H
    Neurol Neuroimmunol Neuroinflamm; 2024 May; 11(3):e200217. PubMed ID: 38547427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral response to Epstein-Barr virus in patients with multiple sclerosis treated with B cell depletion therapy.
    Rød BE; Wergeland S; Bjørnevik K; Holmøy T; Ulvestad E; Njølstad G; Myhr KM; Torkildsen Ø
    Mult Scler Relat Disord; 2023 Nov; 79():105037. PubMed ID: 37804765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis.
    Lünemann JD; Tintoré M; Messmer B; Strowig T; Rovira A; Perkal H; Caballero E; Münz C; Montalban X; Comabella M
    Ann Neurol; 2010 Feb; 67(2):159-69. PubMed ID: 20225269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cumulative Roles for Epstein-Barr Virus, Human Endogenous Retroviruses, and Human Herpes Virus-6 in Driving an Inflammatory Cascade Underlying MS Pathogenesis.
    Meier UC; Cipian RC; Karimi A; Ramasamy R; Middeldorp JM
    Front Immunol; 2021; 12():757302. PubMed ID: 34790199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansion of EBNA1-specific effector T cells in posttransplantation lymphoproliferative disorders.
    Jones K; Nourse JP; Morrison L; Nguyen-Van D; Moss DJ; Burrows SR; Gandhi MK
    Blood; 2010 Sep; 116(13):2245-52. PubMed ID: 20562330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis.
    Tschochner M; Leary S; Cooper D; Strautins K; Chopra A; Clark H; Choo L; Dunn D; James I; Carroll WM; Kermode AG; Nolan D
    PLoS One; 2016; 11(2):e0147567. PubMed ID: 26849221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EBV-specific immune responses in patients with multiple sclerosis responding to IFNβ therapy.
    Comabella M; Kakalacheva K; Río J; Münz C; Montalban X; Lünemann JD
    Mult Scler; 2012 May; 18(5):605-9. PubMed ID: 22020417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Children with endemic Burkitt lymphoma are deficient in EBNA1-specific IFN-gamma T cell responses.
    Moormann AM; Heller KN; Chelimo K; Embury P; Ploutz-Snyder R; Otieno JA; Oduor M; Münz C; Rochford R
    Int J Cancer; 2009 Apr; 124(7):1721-6. PubMed ID: 19089927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid CD4+ T cells from a multiple sclerosis patient cross-recognize Epstein-Barr virus and myelin basic protein.
    Holmøy T; Kvale EØ; Vartdal F
    J Neurovirol; 2004 Oct; 10(5):278-83. PubMed ID: 15385250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with Epstein Barr virus-positive lymphomas have decreased CD4(+) T-cell responses to the viral nuclear antigen 1.
    Heller KN; Arrey F; Steinherz P; Portlock C; Chadburn A; Kelly K; Münz C
    Int J Cancer; 2008 Dec; 123(12):2824-31. PubMed ID: 18781564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.